275 related articles for article (PubMed ID: 19959593)
1. Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.
Clayton CC; Bruchas MR; Lee ML; Chavkin C
Mol Pharmacol; 2010 Mar; 77(3):339-47. PubMed ID: 19959593
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy.
McLaughlin JP; Chavkin C
Mol Pharmacol; 2001 Jun; 59(6):1360-8. PubMed ID: 11353794
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase.
Pak Y; O'Dowd BF; Wang JB; George SR
J Biol Chem; 1999 Sep; 274(39):27610-6. PubMed ID: 10488100
[TBL] [Abstract][Full Text] [Related]
4. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
Melkes B; Hejnova L; Novotny J
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
[TBL] [Abstract][Full Text] [Related]
5. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML
J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267
[TBL] [Abstract][Full Text] [Related]
6. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
Cinar R; Szücs M
J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
[TBL] [Abstract][Full Text] [Related]
7. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
8. Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner.
Santhappan R; Crowder AT; Gouty S; Cox BM; Côté TE
J Neurochem; 2015 Oct; 135(1):76-87. PubMed ID: 26119705
[TBL] [Abstract][Full Text] [Related]
9. Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.
Wang H; Guang W; Barbier E; Shapiro P; Wang JB
Neuroreport; 2007 Dec; 18(18):1969-73. PubMed ID: 18007196
[TBL] [Abstract][Full Text] [Related]
10. Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the micro-opioid receptor.
Schröder H; Wu DF; Seifert A; Rankovic M; Schulz S; Höllt V; Koch T
Neuropharmacology; 2009 Mar; 56(4):768-78. PubMed ID: 19162047
[TBL] [Abstract][Full Text] [Related]
11. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling.
Hou Y; Tan Y; Belcheva MM; Clark AL; Zahm DS; Coscia CJ
Brain Res Dev Brain Res; 2004 Jul; 151(1-2):149-57. PubMed ID: 15246701
[TBL] [Abstract][Full Text] [Related]
13. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Traynor JR; Nahorski SR
Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
[TBL] [Abstract][Full Text] [Related]
14. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
[TBL] [Abstract][Full Text] [Related]
15. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
16. The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.
Petraschka M; Li S; Gilbert TL; Westenbroek RE; Bruchas MR; Schreiber S; Lowe J; Low MJ; Pintar JE; Chavkin C
Neuroscience; 2007 Jun; 146(4):1795-807. PubMed ID: 17467916
[TBL] [Abstract][Full Text] [Related]
17. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia.
Ueda H; Inoue M; Matsumoto T
J Neurosci; 2001 May; 21(9):2967-73. PubMed ID: 11312280
[TBL] [Abstract][Full Text] [Related]
19. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization.
Miess E; Gondin AB; Yousuf A; Steinborn R; Mösslein N; Yang Y; Göldner M; Ruland JG; Bünemann M; Krasel C; Christie MJ; Halls ML; Schulz S; Canals M
Sci Signal; 2018 Jul; 11(539):. PubMed ID: 30018083
[TBL] [Abstract][Full Text] [Related]
20. Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.
Chu J; Zheng H; Zhang Y; Loh HH; Law PY
Cell Signal; 2010 Apr; 22(4):684-96. PubMed ID: 20043990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
